Wichittra Tassaneeyakul Selected Research

Wichittra Tassaneeyakul Research Topics

Disease

15	Stevens-Johnson Syndrome (Lyell's Syndrome) 01/2023 - 09/2009
15	Cicatrix (Scar) 01/2023 - 09/2009
7	Drug-Related Side Effects and Adverse Reactions 01/2022 - 09/2009
7	Cholangiocarcinoma 08/2017 - 01/2008
6	Neoplasms (Cancer) 01/2019 - 01/2012
5	Infections 01/2021 - 01/2006
5	Hypersensitivity (Allergy) 01/2021 - 06/2014
4	Eosinophilia 01/2023 - 05/2016
4	Epilepsy (Aura) 12/2022 - 03/2012
4	Drug Hypersensitivity Syndrome 01/2021 - 12/2017
3	Pneumonia (Pneumonitis) 12/2022 - 08/2015
2	Bipolar Disorder (Manic Depressive Psychosis) 12/2022 - 01/2017
2	Trigeminal Neuralgia (Tic Douloureux) 12/2022 - 04/2018
2	Neutropenia 04/2022 - 01/2021
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 04/2022 - 03/2021
2	Leprosy (Hansen's Disease) 01/2021 - 12/2017
2	Inflammation (Inflammations) 04/2018 - 08/2014
2	Gout 01/2018 - 01/2014
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2006 - 07/2004
1	Acute Generalized Exanthematous Pustulosis 01/2023
1	Chronic Pain 12/2022
1	Acquired Immunodeficiency Syndrome (AIDS) 12/2022
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2021
1	Leukopenia 01/2021
1	Iatrogenic Disease 01/2021
1	Heart Failure 01/2019
1	Erythema 01/2019
1	Cardiotoxicity 01/2019
1	Wounds and Injuries (Trauma) 01/2019
1	Alopecia (Baldness) 01/2019
1	Pain (Aches) 04/2018
1	Drug Hypersensitivity (Drug Allergy) 12/2017
1	Carcinogenesis 08/2017
1	Cardiac Arrhythmias (Arrythmia) 06/2017
1	Brugada Syndrome 06/2017
1	Lymphatic Metastasis 08/2014
1	Partial Epilepsies (Epilepsy, Partial) 07/2013

Drug/Important Bio-Agent (IBA)

18	HLA-B Antigens (HLA-B)IBA 01/2023 - 09/2009
8	Carbamazepine (Tegretol)FDA LinkGeneric 12/2022 - 05/2010
7	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 01/2023 - 08/2015
7	Allopurinol (Remid)FDA LinkGeneric 01/2018 - 09/2009
5	HLA Antigens (Human Leukocyte Antigens)IBA 01/2023 - 01/2014
4	Genetic Markers (Genetic Marker)IBA 01/2023 - 03/2012
4	Cytochrome P-450 CYP2C9IBA 01/2021 - 05/2016
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 08/2015
3	HLA-A Antigens (HLA-A)IBA 01/2023 - 01/2017
3	EnzymesIBA 03/2021 - 08/2012
3	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2021 - 03/2012
3	Dapsone FDA Link 01/2021 - 12/2017
3	Phenytoin (Dilantin)FDA LinkGeneric 01/2019 - 05/2016
3	Proteins (Proteins, Gene)FDA Link 04/2018 - 01/2007
2	Anticonvulsants (Antiepileptic Drugs)IBA 12/2022 - 07/2013
2	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 04/2022 - 03/2021
2	Cytochrome P-450 CYP3AIBA 01/2021 - 01/2007
2	SulfonamidesIBA 01/2021 - 08/2015
2	Messenger RNA (mRNA)IBA 04/2018 - 08/2012
2	Oxcarbazepine (Trileptal)FDA LinkGeneric 01/2018 - 01/2017
2	abacavir (Ziagen)FDA Link 01/2018 - 06/2014
2	Fluorouracil (Carac)FDA LinkGeneric 08/2012 - 01/2008
2	Codon (Codons)IBA 01/2006 - 07/2004
1	HLA-B57 antigenIBA 01/2023
1	HLA-C Antigens (HLA-C)IBA 01/2023
1	HLA-DRB1 Chains (HLA DRB1)IBA 01/2023
1	beta-LactamsIBA 01/2023
1	HLA-DQA1 antigen (HLA DQA1)IBA 01/2023
1	beta Lactam AntibioticsIBA 01/2023
1	HLA-DQB1 antigen (HLA DQB1)IBA 01/2023
1	antineoplaston A10 (A 10)IBA 04/2022
1	Epoxide HydrolasesIBA 01/2022
1	NucleosidesIBA 03/2021
1	Diphosphates (Pyrophosphates)IBA 03/2021
1	thiopurine methyltransferase (thiopurine S-methyltransferase)IBA 03/2021
1	Cytochrome P-450 CYP2C19IBA 01/2021
1	Sulfamethoxazole FDA LinkGeneric 01/2021
1	2-mercaptopurineIBA 01/2021
1	micaIBA 01/2021
1	Antineoplastic Agents (Antineoplastics)IBA 01/2019
1	AnthracyclinesIBA 01/2019
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2019
1	human ERBB2 proteinIBA 01/2019
1	Trastuzumab (Herceptin)FDA Link 01/2019
1	coenzyme Q10 (CoQ10)IBA 04/2018
1	CytokinesIBA 04/2018
1	Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaIBA 04/2018
1	Interleukin-18 (Interleukin 18)IBA 04/2018
1	AntioxidantsIBA 04/2018
1	Probenecid (Benemid)FDA LinkGeneric 01/2018
1	OligonucleotidesIBA 12/2017
1	Amino Acid Transport Systems (Amino Acid Transporter)IBA 08/2017
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	Lamotrigine (Lamictal)FDA LinkGeneric 01/2017
1	HLA-B56 antigenIBA 05/2016
1	CytochromesIBA 05/2016
1	Dinoprostone (PGE2)FDA Link 08/2014
1	Indicators and Reagents (Reagents)IBA 08/2014
1	Nevirapine (Viramune)FDA Link 06/2014
1	salicylhydroxamic acid (SHAM)IBA 07/2013

Therapy/Procedure

7	Therapeutics 01/2021 - 05/2007
1	Oral Administration 01/2019
1	Defibrillators (Defibrillator) 06/2017